CalMatters reported a 16% eye-exam rate for Medi-Cal kids

What CalMatters found

Those are dated descriptive findings, not a live statewide baseline, proof of one cause, or a forecast for a particular FQHC. California also has school vision-screening requirements (Education Code §49455). Before a pilot, confirm need, scope, capacity, payer treatment, partner terms, and clinical ownership.

The 16%, 19%, and 47-of-58 figures describe the periods and measures used in the April 2026 CalMatters report. They should remain attached to that source and date; they do not establish a rural premium, a current county rate, or the needs of an individual child.

CalMatters also reported fee and provider-participation estimates attributed to California Optometric Association testimony. Treat those as reported advocacy context—not a current fee schedule, allowed amount, causal estimate, or payment guarantee. Verify the current DHCS vision benefit, payer contract, delegated arrangement, and provider directory directly.

A screening-to-exam gap can reflect multiple constraints: family preference, communication, transportation, appointment supply, eligibility, network accuracy, referral ownership, language access, and follow-up capacity. A local assessment should measure each step instead of assigning one root cause from statewide reporting.

Define the handoff before choosing a model

Vision To Learn and Warby Parker's Pupils Project publish descriptions of school-based work. Those materials can identify organizations to investigate; they do not establish current local capacity, eligibility, service scope, superiority, or a guaranteed referral pathway.

Screening, refraction, dispensing, comprehensive examination, and specialty care are different functions. Clinical and operations owners should map who performs each function, what falls outside each participant's scope, and who owns urgent, routine, ungradable, and incomplete follow-up.

A 2024 published study estimated on-site vision-service availability among FQHCs using its definitions and data. It is useful background, not a current census or proof that an FQHC clinic is the right answer. Compare on-site care, contracted referral, mobile partnership, school collaboration, and no-build workflow improvements against local evidence.

Check the FQHC option

Use the current DHCS vision-benefit materials and the member's plan to verify eligibility, covered services, frequency, medical-necessity rules, replacement, network, authorization, and patient responsibility. Do not infer one child's benefit from a summary.

Have billing and compliance owners verify whether a proposed service is in approved scope, who may render it, the relevant code, payer and delegated-vendor rules, FQHC encounter treatment, allowed amount, denials, collections, and documentation. Neither a historical fee example nor an editable PPS input is a floor, typical rate, or payment guarantee.

Build the local case from documented need, workforce, space, credentialing, equipment, referral capacity, patient experience, accessibility, total lifecycle cost, and verified payer terms. The worksheet at Vision Strategy contains editable illustrative inputs and transparent arithmetic—not a demand, revenue, profit, or payback forecast.

California statutes such as AB 407 provide legal context, not automatic authority for every service. Legal and clinical leaders must confirm current licensure, certification, privileges, supervision, facility, payer, and referral requirements for the proposed workflow.

Questions for a school–FQHC agreement

Start with a capacity conversation, not a presumed partner or pipeline. Confirm geography, eligibility, consent, clinical scope, referral volume, scheduling capacity, transportation, language and disability access, records exchange, escalation, funding, termination, and named ownership in writing.

Let privacy, legal, clinical, school, and family stakeholders define FERPA/HIPAA responsibilities and realistic service levels. Example response times are discussion inputs, not universal compliance rules or promises to families.

Clinical leaders should approve age-appropriate testing, equipment, staff competencies, urgent escalation, replacement, and follow-up protocols. Coverage for a frame, exam, replacement, or transport must be checked for the individual pathway before it is represented as available.

Assistance organizations may be resources to investigate. Verify current eligibility, geography, inventory, capacity, wait time, clinical limits, privacy terms, and application status; their public materials do not establish that they will fund or complete a local referral.

Planning scenarios

A useful scenario begins with the site's eligible population and verified baseline, then makes completion, ramp, capacity, payer mix, allowed amounts, denials, collections, labor, equipment, referrals, and total cost editable. Label every output as illustrative. Do not call a default conservative, typical, a floor, sustainable, or expected.

NACHC's 2025 Vision Services Expansion brief is an advocacy document containing a national funding proposal and modeled reach. It does not establish an appropriation, a California allocation, local unmet demand, or outcomes.

Verify current rate-setting, NHSC discipline and site eligibility, Section 330 scope, grant terms, 340B permissibility, and pending legislation from the responsible primary source. Advocacy proposals and pending bills are not current benefits, funding approvals, or launch authority.

Options for a health center

Pair the 16% figure with your own referral, completion, patient-experience, safety, equity, workforce, and capacity data.

Possible responses include repairing an existing referral loop, contracting with a qualified provider, testing a school or mobile partnership, or evaluating an on-site service. None is automatically best, and the public evidence does not establish that the economics work at a particular site.

Use the conditional vision diligence sequence to assign owners, verify current sources, define stop conditions, and decide whether a small reversible pilot is justified. No procurement or launch should occur without clinical, finance, compliance, legal, privacy, security, accessibility, operations, and governance approval.